Who are we?
TORSKAL is the pioneer of green nanotechnology in the world. We design disruptive gold nanoparticles by means of a patented and environmentally friendly process from green chemistry using medicinal plant extracts from the Indian Ocean to treat cancer. Our Nanotheranostics Project – NT1, a treatment for skin cancer using near-infrared (IR) radiation-induced plasmonic phototherapy consisting of these gold nanoparticles is planned to undergo clinical trials in 2022.
We are committed to expanding France’s influence in Asia through a joint venture from preclinical trials. The research and production of our nanoparticles are carried out in China, Reunion Island, France, and Germany.
Our gold nanoparticles produced from a patented method using green chemistry will have the following benefits in cancer therapy:
Minimized side effects on patient’s body
Single dose to destroy cancer cells
Treats only the cancer cells without affecting healthy cells
Non-toxic as they are developed from green chemistry
The goal of our health research programs
To find new therapeutic solutions while enhancing the value of the bio-resources that are themselves involved in the manufacture of nanoparticles (NPs).
Revolutionizing cancer care
Our synthesis process ‘know-how’ to obtain versatile NPs leads to many therapeutic strategy combinations
Responsible approach
We use ethical gold sourced from responsible mining organization to develop our gold nanoparticles
Non-toxic method
Due to green chemistry method, our gold NPs are non-toxic, inert, non-oxidizable, and also biocompatible
Ecological process
Green synthesis of NPs without the use of organic solvents & leveraging the Indian Ocean biodiversity
Our Research
All our research programs from skin cancer, deep cancer, nanoparticles to medicinal plant selection.
Nanotheranostics Project - NT1
Nanotheranostics Project – NT1 is our first and main program. It relates to the treatment of skin cancers by photothermal therapy combined with our patented gold nanoparticles. The product is a class 3 medical device and it is planned to undergo clinical trials in 2022.
Deep Cancer Project - NT2
Deep Cancer project – NT2 aims to develop new nanotheranostics for the treatment of deep cancers. We are currently working to optimize the couple nanoparticles – irradiation modalities by testing different types of nanoparticles. This project is currently in the drug design phase.
Dermoscosmetics - Nanoflower Project
Nanoflower Project aims to develop a new cosmetic ingredient using gold particles that is distinct from that used in health. They are larger and are not absorbed through the skin. When combined with light therapy, they provide skin protection properties after radiotherapy.
The Synthesis of Nanoparticles
The nanoparticles (NPs) offered by TORSKAL are produced by green chemistry with crude and/or purified extracts from plants. These extracts have double action of reducing the metal and stabilizing the formed NPs. During synthesis, they can be modulated by various factors.
Medicinal Plant Selection
TORSKAL devotes part of its research activities to the screening of new plant species available in Reunion Island in order to develop new nanotheranostics solutions. Before selecting them, we consider the possible in vivo side effects induced by their extracts.
Latest News
Covering press releases and press articles
